Abstract:
There is provided herein a disparate use bandage comprising a pad portion and an elongate wrapping portion attached at an end thereof to an edge of said pad portion, said pad portion comprising an outer layer, at least one absorbent layer, an inner layer formed of a generally non-permeable material which is attached to the remainder of said pad portion in a readily removable manner.
Abstract:
An elongate strip of an integral reticulated elastomeric polymer material, in which the mesh dimension thereof is substantially larger than the filaments, and which has surface protuberances, is appropriate for therapeutic use as a bandage by wrapping it around a body part so that layers thereof are superimposed and interlock without occlusion of the body.
Abstract:
There is disclosed an extensible article comprising an extensible fabric and an indicator for showing when the fabric has reached a predetermined degree of extension, a method for forming such articles and a method of treatment of venous disorders comprising applying said article to an affected site on a patient.
Abstract:
The invention provides a stabilizing cover to wear over an IV site or any type of wound that requires a protective pad and needs to be accessed or observed often. The device's opening/closure allows doctors, nurses, and other care-givers to check the wound site without the discomfort and inconvenience of removing adhesive tape that is typically used to secure a bandage to the wound site. Using the present invention, IV sites may be checked or changed without pulling up or down and possibly pulling the IV out. The cover also can secure gauze or other wound coverings over the wound site without use of adhesives on the patient's skin. Various sizes of snag-free fasteners, in accordance with the present invention, are used to simplify and expedite the process of checking the site. The stabilizing cover is made of fabric that is flexible, comfortable and disposable.
Abstract:
A roll of perforated, elastic wrap including a plurality of longitudinally spaced, laterally extending, perforated separation lines defined by a series of about 0.2 to 5 mm perforations separated by about 0.1 to 1 mm connecting segments of dressing where the ratio of perforation length to connecting segment length in each separation line is about 1:1 to 10:1 wherein the wrap can be longitudinally elongated between about 7 to 280 percent.
Abstract:
A reusable, releasably fastening tape (12). A double sided (14, 18) releasably fastening tape (12) is provided with a hook (16) and loop (20) type fastening mechanism for self sticking. The tape (12) has perforations (108) therein and cutout portions (106) therefrom, which lend flexibility to the tape, enabling better taping, especially with thicker taping materials. Ideally, the cutout portions (106) are staggered along the edges, and perforations (108) are staggered along offsetting rows, wherein cutouts (106) are adjacent laterally but toward the opposite edge (110) of the tape from a perforation (108). The tape is useful for taping athletes, thus avoiding use of disposable type conventional adhesive tape.
Abstract:
A bandage for improved wound care is disclosed. The bandage comprises a non-adherent, deformable inner layer, a leak-proof outer layer that is substantially coextensive with the inner layer, and an absorbent middle layer contacting both the inner and outer layers. An adhesive strip and adhesive tabs along the bandage's side attach and adjust the fit of the bandage to securely hold the absorbent layer in contact with the wound, without any adhesive touching the skin, thereby eliminating pain and discomfort upon removal or replacement. The bandage allows substantial freedom of motion without slipping. The adhesive strip and tabs secure the bandage in place without any adhesive touching the skin, thereby providing convenience and causing no pain or discomfort upon removal or replacement of the bandage. The bandage may use a non-stick netting material layer to improve patient comfort, and elastic cuffs to improve fit and leakage.
Abstract:
A transdermal medicament patch (18,0168) includes a substrate(32, 172) having a therapeutic face (40, 180) configured for disposition against the skin (102), an adhesive on the therapeutic face (40, 180), a planar medicament matrix (46, 188) covering a portion of the therapeutic face (46,188), and a release liner (41, 182) covering the portion of therapeutic face (40, 180) not obscured by the medicament matrix (46, 188) An aperture (44, 186) through the release liner (41, 182) affords access to the medicament matnx (46, 188) An active electrode (54, 110, 120, 130, 140, 150, 210, 230, 250,270, 290) positioned between the medicament matrix (46,188) and the therapeutic face (40, 180) includes an electpcally conductive backing layer (56, 142, 152,212,232,252,272, 292) positioned against the therapeutic face (40, 180) and a pH-control layer (58, 132, 146, 156,216, 236, 256, 276, 296) that moderates changes in hydrogen-ion concentration covering
Abstract:
A transdermal medicament patch ( 18,0168) includes a substrate(32, 172) having a therapeutic face (40, 180) configured for disposition against the skin (102), an adhesive on the therapeutic face (40, 180), a planar medicament matrix (46, 188) covering a portion of the therapeutic face (46,188), and a release liner (41, 182) covering the portion of therapeutic face (40, 180) not obscured by the medicament matrix (46, 188). An aperture (44, 186) through the release liner (41, 182) affords access to the medicament matrix (46, 188). An active electrode (54, 110, 120, 130, 140, 150, 210, 230, 250, 270, 290) positioned between the medicament matrix (46, 188) and the therapeutic face (40, 180) includes an electrically conductive backing layer (56, 142, 152, 212, 232, 252, 272, 292) positioned against the therapeutic face (40, 180) and a pH-control layer (58, 132, 146, 156, 216, 236, 256, 276, 296) that moderates changes in hydrogen-ion concentration covering less than all of the therapeutic face (40, 180). One active electrode design criterion relates the size of the pH-control layer to the size of the backing layer; another relates the size of the portion of the backing layer not covered by the pH-control layer to the size of the pH-control layer.
Abstract:
A low temperature thermoplastic material for use in medical procedures including radiotherapy patient immobilization, orthopedic splinting or casting, plastic and reconstructive surgery splinting, and orthotic or prosthetic socket cone production or reproduction. The material is made from a thermoplastic that softens when heated to approximately 140°F, after which it can then be formed directly on the patient. The material will then retain this new shape as it cools. The material is composed of Polycaprolactone reinforced with a discontinuous short length fiber and/or fines. The device can also be cross-linked to improve its handling properties.